mRNA |
AA-COCF3 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.6 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.6 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.025 |
0.6 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
lapatinib |
UHNBreast |
pan-cancer |
AAC |
-0.15 |
0.6 |
mRNA |
CAY10576 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.6 |
mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |